5/6/2013
Bio-Rad Laboratories Life Science Group
Raleigh,
NC
The technical support specialist uses their background and experience in science to answer customer and internal inquiries by phone, e-mail and fax regarding the entire product line and applications associated with those products, and they check...
5/6/2013
BioSpace Career Fairs
San Francisco,
CA
Biotech Bay Career Fair
San Francisco Airport Waterfront Marriott
Thursday, June 6, 2013
1pm to 6pm
EXHIBITING COMPANIES
Bayside Solutions, Inc.
California Applied Biotechnology Centers Initiative
Integrated Project Management
More To Come!!!
5/6/2013
Ambrx, Inc.
San Diego,
CA
Ambrx is a biopharmaceutical company enabling a new field of protein medicinal chemistry, using a fundamentally new technology that directs incorporation of amino acids beyond nature’s conserved set into biosynthetic proteins to produce high value...
5/6/2013
Ambrx, Inc.
San DIego,
CA
Ambrx is a biopharmaceutical company enabling a new field of protein medicinal chemistry, using a fundamentally new technology that directs incorporation of amino acids beyond nature’s conserved set into biosynthetic proteins to produce high value...
5/3/2013
University of California, San Francisco (UCSF)
San Francisco,
CA
: The University of California San Francisco (UCSF) Sandler-Moore Mass Spectrometry (SMMS) Core Facility has an immediate opening for a scientist at the Assistant Specialist level. The successful candidate will support proteomics research activities...
5/2/2013
ASKGene Pharma, Inc.
Camarillo,
CA
AskGene Pharma, Inc. focuses on development and commercialization of novel and follow on protein theraputics to meet the needs of large patient population. We are seeking a talented and experienced principal analytical scientist to join our southern...
5/2/2013
ARIAD Pharmaceuticals, Inc.
Cambridge,
MA
ARIAD is a Cambridge, Massachusetts-based biotechnology company focused on cancer. We are a cohesive team of talented people from diverse backgrounds with a shared vision: We seek to transform the lives of patients with breakthrough cancer...